Is it safe? Answering that question for therapies based on living cells is not simple.
Darin J. Weber, Ph.D.
Advertisement
Articles by Darin J. Weber, Ph.D.
Advertisement
Latest Updated Articles
Biosafety Considerations for Cell-Based TherapiesPublished: July 1st 2004 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
